The program consists of a cycle of 4 Webinars focused on Castleman Disease developed in collaboration with three experts, all members of the EHA and the ERN-EuroBloodNet: Prof Oksenhendler Eric, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Prof Kai Hübel, Universitätsklinikum Köln, and Prof Simone Ferrero, AOU S.Luigi Gonzaga.
The main objective of this program is to disseminate up-to-date knowledge among interested haematologists, internists, paediatricians, or other health care providers in order to give visibility to cutting-edge advances in the field of Castleman Disease. Castleman Disease has a low prevalence and multiple clinical manifestations, hence the need for education addressing, physiopathology, etiologym diagnosis and treatment. Ultimately, this approach supports better patient care. Webinars will be recorded and the videos will be integrated in the EHA and ERN-EuroBloodNet e-learning environments to create enduring educational material on all types of Castleman disease
This program is accredited by the European Board of Accreditation in Hematology. Participants will receive 1 Continuing Medical Education points when they take part in one online webinar.
EHA & ERN-EuroBloodNet Spotlight on Castleman Disease is conducted using the Zoom Platform. It allows full audio and visual communication, as well as interaction between webinar's speaker and participants. Each Webinars will last one hour including speakers presentation and Questions & Answers session from the hearers. In addition, they are always held on the same day of the week and time slot: Tuesday at 15:00 (CEST), twice per month, from January to March 2022.
N°1 Overview of Castleman Disease (pathophysiology excluded) provided by Kai Hübel and Elena Sabatini – 25th of January 2022
Content: History / Classification / Pathology / Diagnosis
N°2 Unicentric Castleman Disease provided by Eric Oksenhendler – 1st of February 2022
Content: Imaging (cases) / Diagnosis and initial assessment / Complications / Pathophysiology / Treatment
N°3 Idiopathic multicentric Castleman Disease provided by Simone Ferrero - 15th of February 2022
Content: Clinical phenotypes of the disease / Differential diagnosis (including cases) / Relationship with TAFRO, IgG4RD, and POEMS / Pathophysiology / Treatment
N°4 Kaposi sarcoma herpes virus-associated multicentric Castleman disease and HHV-8-associated multicentric Castleman disease (KSHV/HHV8 MCD) provided by Mark Bower and David Boutboul - 8th of March 2022
Content: Diagnosis / Complications / Pathophysiology / Treatment